Intro
Biopharma Cold Chain 2011 Sourcebook
The Biopharma Cold Chain 2011 Sourcebook is a comprehensive business guide to the world’s supply chain for temperature-sensitive drugs and biologics. The updated 2011 edition provides an assessment and forecast of cold-chain logistics spending worldwide, and a detailed and up-to-date analysis of regulatory, market, technological and business developments that are expanding the demand for temperature-assured storage and transportation and improving the supply chain’s ability to deliver that assurance.
By Mark Lipowicz and Nicholas Basta, Pharmaceutical Commerce
and Editorial Adviser: Rafik Bishara, PhD, Pharmaceutical Cold Chain Interest Group
The Biosimilars Landscape Through the Eyes of an Economist
February 21st 2025James D. Chambers, PhD, MPharm, MSc, professor of medicine at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies, dives into why biosimilars contribute to a reduction in cost and increase in patient access, while highlighting challenges to adoption.
